0001062993-14-006901.txt : 20141125 0001062993-14-006901.hdr.sgml : 20141125 20141125162756 ACCESSION NUMBER: 0001062993-14-006901 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141124 FILED AS OF DATE: 20141125 DATE AS OF CHANGE: 20141125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schamroth Michael CENTRAL INDEX KEY: 0001375385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 141249955 MAIL ADDRESS: STREET 1: 191 MEADOWVIEW AVENUE CITY: HEWLETT STATE: NY ZIP: 11557 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2014-11-24 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375385 Schamroth Michael C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2014-11-24 4 S 0 4499 39.3560 D 30000 D The selling price of $39.3560 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.20 to $39.50. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Michael Schamroth by Carl A. Valenstein, attorney-in-fact 2014-11-25